- Home
- HNST vs IKT Comparison
HNST vs IKT Comparison
Compare HNST & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | IKT |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.3M | 240.1M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HNST | IKT |
|---|---|---|
| Price | $2.93 | $1.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $3.05 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 05-06-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $371,317,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.93 | $33.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.07 | $1.33 |
| 52 Week High | $5.52 | $2.37 |
Technical Indicators
Market Signals| Indicator | HNST | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 47.33 |
| Support Level | $2.38 | $1.43 |
| Resistance Level | $2.98 | $1.88 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 72.88 | 53.03 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.